Streetbeat News

Earnings

MKC

McCormick & Co (NYSE:MKC) is scheduled to release its quarterly earnings report on March 26, 2024. Analysts predict an EPS of $0.58. The company's past earnings performance shows a history of beating EPS estimates, which has occasionally led to a positive impact on its share price the following day. However, shares have declined by 13.97% over the last 52 weeks, indicating a bearish outlook among long-term shareholders. Investors will be particularly attentive to the company's guidance for future growth.

Portfolio Pulse from Benzinga Insights

March 25, 2024 | 5:00 pm

NCNO

Ncino (NASDAQ:NCNO) is scheduled to release its quarterly earnings report on 2024-03-26, with analysts expecting an EPS of $0.12. Historical data shows mixed reactions to past earnings, with the last quarter's beat resulting in a 7.84% share price drop. Shares have risen 36.63% over the last year, indicating positive sentiment among long-term investors.

Portfolio Pulse from Benzinga Insights

March 25, 2024 | 5:00 pm

ROIV

Roivant Sciences (NASDAQ:ROIV) has received mixed analyst ratings in the past three months, with a total of 5 analysts offering their perspectives. The ratings include 2 bullish, 2 somewhat bullish, and 1 indifferent. The average 12-month price target for ROIV has been updated to $17.8, up from $14.50, indicating a 22.76% increase. Analysts from firms such as Truist Securities, Wolfe Research, HC Wainwright & Co., Piper Sandler, and B of A Securities have provided updates, with actions ranging from maintaining to raising and lowering their ratings and price targets. Roivant Sciences, a biopharmaceutical company, has shown impressive financial performance with a revenue growth rate of 117.8%, a net margin of 13721.55%, and ROE of 144.81%.

Portfolio Pulse from Benzinga Insights

March 25, 2024 | 5:00 pm

GME

GameStop (NYSE:GME) is anticipated to report Q4 earnings with a focus on profitability and Ryan Cohen's new role in investing company cash. Analysts expect $2.05 billion in revenue and earnings per share of 29 cents. A significant development is the Board's decision to allow investments in equity securities, overseen by CEO Ryan Cohen, which has been criticized by analysts. Investors are keen on GameStop's investment decisions, future growth opportunities, and the potential impact of digital sales shifts on the company.

Portfolio Pulse from Chris Katje

March 25, 2024 | 4:39 pm

GME

GameStop shares are trading higher in anticipation of the company's Q4 results, which are scheduled to be released tomorrow.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 4:24 pm

BYDDY

DRIV

NIO

TSLA

Tesla Inc (TSLA) is adjusting its strategy to focus on profitability over volume, with price increases for the Model Y in the U.S. and Eurozone amid reports of slowing production in China due to competition and slowing EV sales. Analysts at Oppenheimer believe this shift towards maximizing value per vehicle and leveraging software updates, particularly in Full Self-Driving, could enhance revenue. However, Tesla's stock has declined nearly 32% in 2024, while the Global X Autonomous & Electric Vehicles ETF (DRIV) remains flat. Oppenheimer maintains a Perform market rating for Tesla, highlighting its potential as a transformational technology company.

Portfolio Pulse from Neil Dennis

March 25, 2024 | 4:08 pm

AXSM

Axsome Therapeutics Inc (NASDAQ:AXSM) announced positive results from the SYMPHONY Phase 3 trial of AXS-12 in narcolepsy patients, showing significant improvements in cataplexy attacks, excessive daytime sleepiness, and other symptoms compared to placebo. Despite the positive trial results, AXSM shares dropped 3.84% to $77.56.

Portfolio Pulse from Vandana Singh

March 25, 2024 | 4:08 pm

SIDU

Sidus Space (NASDAQ:SIDU) is scheduled to release its quarterly earnings report on March 26, 2024, with analysts expecting an EPS of $0.00. The company's past earnings performance shows a trend of missing EPS estimates, leading to significant drops in share price. Shares are currently trading at $3.56, down 93.45% over the last 52 weeks. Investors are looking for positive guidance for the next quarter.

Portfolio Pulse from Benzinga Insights

March 25, 2024 | 4:08 pm

DRCT

Direct Digital Holdings (NASDAQ:DRCT) is scheduled to release its quarterly earnings report on 2024-03-26, with analysts estimating an EPS of $0.26. The company's historical performance shows significant share price movements following earnings announcements, with a 54.79% increase after last quarter's beat. Shares are currently trading at $26.34, up 789.77% over the last 52 weeks, indicating strong long-term shareholder returns.

Portfolio Pulse from Benzinga Insights

March 25, 2024 | 4:08 pm

RCUS

Arcus Biosciences (NYSE:RCUS) received mixed analyst ratings with 2 bullish and 3 somewhat bullish out of 5 total. The average 12-month price target was adjusted to $37.6, down 13.56% from previous estimates. Analysts from Truist Securities and Wedbush maintained their ratings, while Mizuho lowered its price target. The company, a clinical-stage biopharmaceutical firm focusing on cancer immunotherapies, showed a revenue decline of -8.82% and a net margin of -261.29%, indicating financial challenges.

Portfolio Pulse from Benzinga Insights

March 25, 2024 | 4:08 pm